Jupiter Neurosciences, Inc. (NASDAQ: JUNS) Stock Information | RedChip
Image

ASK REDCHAT® ANYTHING ABOUT JUPITER NEUROSCIENCES, INC.

Jupiter Neurosciences, Inc. (NASDAQ: JUNS)
Listen to this Section


$1.04
-0.0400 ( -4.59% ) 425.7K

Jupiter Neurosciences, Inc. is a clinical-stage pharmaceutical company focused on treating neuroinflammation, with a current focus on CNS disorders and rare diseases. The Company's platform product, JOTROL™, is an enhanced orally administered resveratrol formulation designed and intended to deliver therapeutically relevant, safe levels of resveratrol. The Company's pipeline is focused broadly on CNS disorder and includes indications such as Alzheimer's Disease, Parkinson's Disease, Mucopolysaccharidoses Type I, Friedreich's Ataxia, and MELAS.

Market Data


Open $1.04
Previous Close $1.08
Volume 425.7K
Market Cap $34.76M
Day Range $1.01 - $1.12
52 Week Range $0.91 - $19.51
Shares Outstanding 33.10M
Change % -4.59%
Net Change ▼ -0.0400
Insider Ownership N/A
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
IPO Year 2024
Country United States
Under Writer Dominari Securities, Revere Securities, more

Insider Ownership Transactions

Total Amount Purchased: 0.00

Date Type Amount Purchased Purchaser
No records found.

Institutional Ownership

Total Market Value $ 0.00

Symbol Issuer Name Market Value ↓ Share Quantity
No records found.

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 59 Dec 23, 2024
8-k 8K-related 14 Dec 20, 2024
8-k 8K-related 22 Dec 19, 2024

Latest News


× Before browsing our site, please accept our cookies policy